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ABSTRACT Porphyrins are intermediate metabolites in the biosynthesis of vital mol-
ecules, including heme, cobalamin, and chlorophyll. Bacterial porphyrins are known
to be proinﬂammatory, with high levels linked to inﬂammatory skin diseases. Propi-
onibacterium species are dominant skin commensals and play essential roles in de-
fending against pathogens and in triggering an inﬂammatory response. To better
understand how the inﬂammatory potential of the skin microbiome may vary de-
pending on its propionibacterial composition, we compared the production levels
of porphyrins among Propionibacterium acnes, Propionibacterium granulosum, Propi-
onibacterium avidum, and Propionibacterium humerusii strains. We found that por-
phyrin production varied among these species, with P. acnes type I strains producing
signiﬁcantly larger amounts of porphyrins than P. acnes type II and III strains and
other Propionibacterium species. P. acnes strains that are highly associated with the
common skin condition acne vulgaris responded to vitamin B12 supplementation
with signiﬁcantly higher porphyrin production. In contrast, vitamin B12 supplementa-
tion had no effect on the porphyrin production of health-associated P. acnes strains
and other propionibacteria. We observed low-level porphyrin production in most
Propionibacterium strains harboring the deoR repressor gene, with the exception of
P. acnes strains belonging to type I clades IB-3 and IC. Our ﬁndings shed light on
the proinﬂammatory potential of distinct phylogenetic lineages of P. acnes as well as
other resident skin propionibacteria. We demonstrate that the overall species and
strain composition is important in determining the metabolic output of the skin mi-
crobiome in health and disease.
IMPORTANCE Porphyrins are a group of metabolites essential to the biosynthesis of
heme, cobalamin, and chlorophyll in living organisms. Bacterial porphyrins can be
proinﬂammatory, with high levels linked to human inﬂammatory diseases, including
the common skin condition acne vulgaris. Propionibacteria are among the most
abundant skin bacteria. Variations in propionibacteria composition on the skin may
lead to different porphyrin levels and inﬂammatory potentials. This study character-
ized porphyrin production in all lineages of Propionibacterium acnes, the most domi-
nant skin Propionibacterium, and other resident skin propionibacteria, including P.
granulosum, P. avidum, and P. humerusii. We revealed that P. acnes type I strains pro-
duced signiﬁcantly more porphyrins than did type II and III strains and other Propi-
onibacterium species. The ﬁndings from this study shed light on the proinﬂamma-
tory potential of the skin microbiome and can be used to guide the development of
effective acne treatments by modulating the skin microbiome and its metabolic ac-
tivities.
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Over the last decade, with the advancements in microbiome studies, great strideshave been made in our understanding of the microbial composition at different
human body sites. In many cases, however, the functions and metabolic activities of
these microbial communities and their interactions with the host are still not well
understood.
Porphyrins are a group of metabolites involved in the biosynthesis of molecules
essential to life (1, 2). Their characteristic tetrapyrrole ring-like structure allows them to
bind metal ions such as iron and magnesium, facilitating their primary role as inter-
mediates in heme and chlorophyll biosynthesis pathways, respectively (3). A build-up
of bacterial porphyrins is also believed to play roles in human disease. Porphyrin levels
on the skin of patients suffering from the common skin disease acne vulgaris (acne) are
found to be signiﬁcantly higher prior to successful treatment with antimicrobial ther-
apies (4). The dominant porphyrin species produced by Propionibacterium acnes, co-
proporphyrin III, was shown to induce Staphylococcus aureus aggregation and bioﬁlm
formation in the nostrils (5). Porphyrin intermediates in bacterial heme biosynthesis
pathways have been shown to induce inﬂammatory responses in human cells (6).
Furthermore, coincubation of human keratinocytes with the synthetic coproporphyrin
III tetramethyl ester has been shown to stimulate an increase in interleukin 8 (IL-8)
expression after a 3-h incubation (6), supporting a role for porphyrins in skin inﬂam-
mation.
We previously investigated the production of porphyrins by the dominant skin
species P. acnes. P. acnes is classiﬁed into three subspecies and further into multiple
phylogenetic clades that are known to differ in their virulence potential and associa-
tions with diseases (7–10). Comparison of porphyrin production from strains belonging
to types I and II revealed signiﬁcantly higher production levels in acne-associated
strains (type I clade IA-2) than in strains associated with skin health (type II). This
suggests that porphyrin production may be an important virulence mechanism helping
to drive the inﬂammatory response seen in acne (8). We also observed that porphyrin
production in P. acnes is modulated by host vitamin B12 levels, which inﬂuence the
transcriptional activities of the skin bacteria in vivo (9). In vitro, vitamin B12 supplemen-
tation downregulates bacterial vitamin B12 biosynthesis and enhances porphyrin pro-
duction in acne-associated clade IA-2 strains but not in health-associated type II strains
(8, 9). Furthermore, comparative genomic analysis uncovered a deoR repressor gene
upstream of the porphyrin biosynthesis operon in health-associated type II strains that
is absent from acne-associated clade IA-2 strains (8). While it remains to be determined
by what mechanisms P. acnes utilizes porphyrins, their production seems to correlate
with the disease association and virulence property of P. acnes strains in acne.
Porphyrin production in P. acnes has been described in a number of independent
studies, with each study often investigating a single type strain or a small number of
clinically isolated strains (5, 6, 8, 11, 12). It is known, however, that individuals harbor
complex skin microbial communities containing multiple Propionibacterium species and
often a mixed P. acnes strain population (7). In fact, P. acnes strains from lineages that
are not signiﬁcantly associated with either acne or health (such as clades IA-1 and IB-2)
represent the most prevalent and abundant strains in both acne patients and healthy
individuals (7). In a recent study, we revealed that the balance between bacterial
species and P. acnes strains is important when considering a role for the microbiome in
skin health and disease. Beyond P. acnes, we also found that Propionibacterium granu-
losum was at a signiﬁcantly higher relative abundance and increased prevalence in
healthy individuals than in acne patients (13). Currently, porphyrin production and
regulation in P. acnes strains beyond disease-associated (clade IA-2) and health-
associated (type II) lineages have not been deﬁned, as well as porphyrin production and
regulation in other cutaneous, and potentially health-conferring, Propionibacterium
species.
To better understand the contributions of the key members of the skin microbiome
to health and disease, in this study, we selected representative P. acnes strains from all
major lineages (type I clades IA-1, IA-2, IB-1, IB-2, IB-3, and IC, type II, and type III) and
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quantitatively compared their porphyrin production levels. Several other major human-
associated propionibacteria, including P. granulosum, Propionibacterium avidum, and
Propionibacterium humerusii were also analyzed. Furthermore, to correlate our quanti-
tative in vitro measurements with clinical applications, we used Wood’s lamp, which is
commonly used by dermatologists during skin examinations, to rapidly visualize por-
phyrin production across different Propionibacterium species and strains.
RESULTS
Porphyrin production is signiﬁcantly higher in P. acnes type I strains. To
compare porphyrin production across all major P. acnes lineages, we selected 16 strains
representative of eight major phylogenetic groups, including type I clades IA-1 (n 2),
IA-2 (n 2), IB-1 (n 2), IB-2 (n 2), IB-3 (n 2), IC (n 1), type II (n 3), and type III
(n 2) (Table 1). We quantiﬁed the levels of secreted porphyrins produced by these
strains (Fig. 1). While individual strains differed in their porphyrin production, type I
strains consistently produced signiﬁcantly higher levels of porphyrins, with an average
of 2.67 M (range, 1.4 to 4.0 M), compared to a much lower average production of
0.04 M observed in type II strains (range, 0.02 to 0.08 M; P 5.2 1026), and
0.37 M observed in type III strains (range, 0.18 to 0.56 M; P 9.8 1024; Fig. 1).
Acne-associated strains respond to vitamin B12 with increased porphyrin pro-
duction, while other strains do not. We investigated and compared the effect of
vitamin B12 on porphyrin production in all major P. acnes lineages, including acne- and
health-associated strains. Previously, we revealed that acne-associated strains from
clade IA-2 responded to vitamin B12 supplementation with increased porphyrin pro-
duction (8). Acne association, deﬁned by Fitz-Gibbon et al. (7) as an acne index, is
assigned to P. acnes ribotypes (RT) based on the frequency of each ribotype identiﬁed
in acne patients versus healthy individuals. A high acne index is representative of a
ribotype identiﬁed with increased frequency in acne patients compared to healthy
individuals. In addition to clade IA-2, strains from clades IB-1 and IC are also highly
associated with acne (7, 14). We measured the porphyrin production from various P.
acnes strains when supplemented with 10 g/ml vitamin B12 in the culture (Fig. 2; see
also Fig. S1 in the supplemental material). We found that strains from the acne-
associated clades IA-2, IB-1, and IC responded positively to vitamin B12 supplementa-
TABLE 1 Propionibacterium strains used in this studya
Species Clade Ribotype MLST8b Strain name Source/clinical association deoRc
P. acnes IA-1 RT1 ST15 HL005PA2 Facial skin No
RT1 ST1 HL027PA2 Facial skin No
IA-2 RT5 ST3 HL043PA1 Facial skin/acne No
RT4 ST3 HL053PA1 Facial skin/acne No
IB-1 RT8 ST4 HL053PA2 Facial skin/acne No
RT8 ST13 HL082PA1 Facial skin/acne No
IB-2 RT3 ST2 HL037PA1 Facial skin No
RT3 ST23 HL063PA2 Facial skin No
IB-3 RT1 ST5 KPA171202 Culture contaminant Yes
RT1 ST5 HL030PA1 Facial skin Yes
IC RT5 ST85 PV66 Unknown/acne Yes
II RT2 ST30 HL001PA1 Facial skin/healthy skin Yes
RT6 ST7 HL042PA3 Facial skin/healthy skin Yes
RT6 ST7 HL110PA3 Facial skin/healthy skin Yes
III NA ST123 HL201PA1 Tooth/endodontitis Yes
NA ST75 BR-16 Back skin/PMH Yes
P. granulosum NA NA NA HL078PG1 Facial skin Yes
NA NA HL082PG1 Facial skin Yes
P. avidum NA NA NA HL063PV1 Facial skin Yes
NA NA HL083PV1 Facial skin Yes
NA NA HL307PV1 Facial skin Yes
P. humerusii NA NA NA HL044PA1 Facial skin Yes
aNA, not assigned; MLST, multilocus sequence type; ST, sequence type.
bData from the MLST8 database (https://pubmlst.org/cacnes/).
cHomolog with deoR sequence PPA0299 from KPA171202.
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tion with signiﬁcantly increased porphyrin production compared to that in nonsupple-
mented controls (clade IA-2, P 0.038; clade IB-1, P 0.015; clade IC, P 0.050; Fig. 2).
In contrast, strains from clades IA-1, IB-2, and IB-3, and in types II and III, which are not
associated with acne, did not respond to vitamin B12 supplementation and did not
produce more porphyrins when supplemented with vitamin B12 (Fig. 2). Thus, the
differences in the overall abundances and ratios of multiple P. acnes strains in individ-
uals may, in part, explain why only a subset of individuals are affected by vitamin
B12-induced acne, as previously described (9, 15, 16).
Other Propionibacterium species produce signiﬁcantly lower levels of porphy-
rins than P. acnes type I strains. In addition to P. acnes, which is the dominant species
found on sebaceous skin, individuals also harbor other cutaneous propionibacteria,
including P. granulosum, P. avidum, and P. humerusii (7, 17). We determined the ability
of these resident propionibacteria to produce porphyrins. We examined three Propi-
onibacterium strains, P. granulosum HL082PG1, P. avidum HL307PV1, and P. humerusii
HL044PA1 (Table 1), which were all isolated from human skin. We observed that all
three strains produced low levels of porphyrins, similar to P. acnes type II and III strains,
with an average porphyrin production of 0.30 M (range, 0.14 to 0.52 M, Fig. 3). This
level is signiﬁcantly lower than that of P. acnes type I strains (P 5.2 1023).
To determine the effect of vitamin B12 on porphyrin production in other propi-
onibacteria, we supplemented P. granulosum, P. avidum, and P. humerusii cultures with
10 g/ml vitamin B12 and measured their porphyrin levels. There was no signiﬁcant
difference in porphyrin production compared to that in control cultures without
vitamin B12 supplementation (Fig. S2). We further validated our ﬁndings using three
additional strains, P. granulosum HL078PG1, P. avidum HL063PV1, and P. avidum
HL083PV1. The results from these three additional Propionibacterium strains further
support our conclusions of low porphyrin production by other Propionibacterium
species regardless of the presence or absence of vitamin B12 supplementation (Fig. S2).
FIG 1 Porphyrin production across all known lineages of P. acnes. Porphyrin production was determined for 16
P. acnes strains representing all known lineages of P. acnes, as displayed on the left. Type I strains produced
signiﬁcantly more porphyrins than did type II and III strains. Porphyrin production is deﬁned as the concentration
of porphyrins produced (in micromolar) normalized by bacterial growth measured as the OD595. The average and
the standard error of the mean (SEM) were calculated based on the data obtained from at least three independent
experiments with at least four replicates each (***, P 0.001). ID, identiﬁer; na, not assigned.
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Presence and expression of deoR in P. acnes strains and other propionibacteria.
In our previous study, we identiﬁed a deoR repressor element upstream of the porphy-
rin biosynthesis operon in P. acnes and suggested that it may play a role in controlling
low levels of porphyrin production in deoR-harboring strains (8). To determine if the
presence of deoR is correlated with low porphyrin production across different P. acnes
strains and other Propionibacterium species, we searched for the deoR gene PPA0299 in
all known genomes of P. acnes and other cutaneous propionibacteria. We found that
the deoR element is present in P. acnes strains from type I clades IB-3 and IC, types II
and III, as well as in strains representing P. avidum, P. granulosum, and P. humerusii
(Table 1). Most deoR-harboring strains produce inherently low levels of porphyrins,
including all tested type II and III P. acnes strains and other cutaneous propionibacteria.
However, we observed moderate-to-high porphyrin production in P. acnes clade IB-3
and IC strains (range, 1.37 to 4.0 M; Fig. 1). We tested for differences in deoR gene
expression between P. acnes strains with high and low porphyrin production levels. We
extracted RNA from log-phase cultures of three deoR-harboring strains, including two
strains that produced high levels of porphyrins, KPA171202 (clade IB-3, 3.38  0.4 M)
and PV66 (clade IC, 4.0  0.67 M), and one strain, HL201PA1, that produced naturally
low levels of porphyrins (type III, 0.56  0.11 M). A deoR-negative strain, HL037PA1,
was used as a negative control. We detected deoR expression in all three deoR-
harboring P. acnes strains (Fig. S3). Since deoR was found to be expressed in both high-
and low-level-porphyrin-producing strains, we sought to determine if there were
differences in the deoR gene sequence that could explain variations in regulation and
porphyrin production among the strains. We aligned deoR sequences from strains
representing major P. acnes types as well as other cutaneous propionibacteria and
constructed maximum likelihood phylogenetic trees (Fig. S4). While there were notable
differences at the nucleotide level, we did not identify any single nucleotide polymor-
phisms (SNPs) that were uniquely shared by strains from clades IB-3 and IC and that
could potentially explain the increased porphyrin production in these lineages. These
results therefore suggest that additional factors likely play a role in the regulation of
porphyrin production and the response to vitamin B12 supplementation.
FIG 2 Acne-associated strains respond to vitamin B12 (VB12) supplementation and produce signiﬁcantly
more porphyrins. Strains from acne-associated P. acnes lineages (type I clades IA-2, IB-1, and IC) produced
signiﬁcantly more porphyrins when supplemented with vitamin B12 (10 g/ml) than did the controls.
Strains from other lineages (type I clades IA-1, IB-2, and IB-3, type II, and type III) did not respond to
vitamin B12 supplementation in porphyrin production. Porphyrin production is deﬁned as the concen-
tration of porphyrins produced (in micromolar) normalized by bacterial growth measured as the OD595.
Each bar represents the average porphyrin production by one or more strains in the same lineage. The
average and the SEM were calculated based on the data obtained from at least three independent
experiments with at least four replicates each (*, P 0.05).
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Conﬁrmation of porphyrin production by propionibacteria using the Wood’s
lamp. The Wood’s lamp is a dermatological tool used in the detection and manage-
ment of many skin-related diseases, including microbial infections, acne, porphyria, and
vitiligo (18). P. acnes ﬂuoresces an orange-pink color when illuminated under a Wood’s
lamp, owing to the production of porphyrins (19, 20). With our observations of different
porphyrin production levels across propionibacteria species, we investigated if there
were variations in the color appearance of different Propionibacterium species and
strains when subjected to a Wood’s lamp examination, which potentially could be
utilized in a clinic setting. We found that P. acnes type I strains producing moderate-
to-high levels of porphyrins appeared orange-pink when plated on solid medium and
illuminated with a Wood’s lamp. In particular, the acne-associated clade IC strain PV66
had the most intense orange-pink color observed, consistent with the highest level of
porphyrins produced by this strain determined by the extraction method, compared to
other type I strains tested (HL037PA1 and KPA171202; both clade IB-3). On the other
hand, type II and III strains produced little, if any, orange-pink color; rather, a white color
was observed for most of these strains, including the type III strains HL201PA1 and
BR-16 (Fig. 4).
We also tested the appearance of P. granulosum and P. humerusii isolates under the
Wood’s lamp. We found that, similar to the low-porphyrin-producing P. acnes strains,
these strains also produced little to no orange-pink color (Fig. 4). The observation of
different colors of Propionibacterium colonies when illuminated with a Wood’s lamp
correlated well with the porphyrin levels quantitatively measured by the extraction
method. These results further validate our conclusions that P. acnes type I strains
contribute most of the porphyrins produced by skin bacteria.
FIG 3 Other cutaneous propionibacteria produce signiﬁcantly lower levels of porphyrins than P. acnes type I strains. Porphyrin
production by three other Propionibacterium species, P. granulosum (HL082PG1), P. avidum (HL307PV1), and P. humerusii (HL044PA1),
was determined and compared to the average levels of porphyrins produced by P. acnes strains from the types I, II, and III lineages.
Other Propionibacterium species produced signiﬁcantly lower levels of porphyrins than did P. acnes type I strains. Porphyrin production
is deﬁned as the concentration of porphyrins produced (in micromolar) normalized by bacterial growth measured as the OD595. The
average and the SEM were calculated based on the data obtained from at least four independent experiments, with at least four
replicates each shown (***, P 0.001; ns, not signiﬁcant).
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DISCUSSION
Porphyrins are proinﬂammatory metabolites that are believed to play a causal role
in inﬂammatory skin conditions (4, 6, 21). Previously, we revealed that acne-associated
P. acnes clade IA-2 strains produce signiﬁcantly higher levels of porphyrins than do type
II strains (8), which are associated with healthy skin (22). Since an individual can harbor
a mixed P. acnes strain population and other Propionibacterium species on the skin, in
this study, we sought to investigate the production of porphyrins across all major
phylogenetic groups of P. acnes, as well as other resident cutaneous propionibacteria.
Our results revealed that most type I strains produced a moderate-to-high level of
porphyrins, in contrast to the little to no production in type II and III strains.
While P. acnes type I strains produce signiﬁcantly more porphyrins than do type II
and III strains (Fig. 1), only strains from acne-associated lineages (clades IA-2, IB-1, and
IC) responded to vitamin B12 supplementation with signiﬁcantly enhanced porphyrin
production (Fig. 2). An increase in the production of proinﬂammatory porphyrins in
strains from these lineages may help explain the association between these strains and
acne. Acne patients harbor higher abundances of strains from clades IA-2, IB-1, and IC,
compared to a low abundance or absence of these strains in healthy individuals (7, 13).
In contrast, healthy individuals often harbor higher abundances of low-porphyrin-
producing strains from the type II lineage (7, 13). Acne patients also tend to have higher
serum vitamin B12 levels than do healthy individuals (23). Increased production of
bacterial porphyrins upon high vitamin B12 levels may therefore lead to the phenom-
enon of vitamin B12-induced acne. Furthermore, individuals harboring complex skin
FIG 4 Wood’s lamp examination of porphyrin production of Propionibacterium strains cultured on solid medium. Eleven Propionibacte-
rium strains were cultured on solid medium plates and illuminated with a Wood’s lamp. Detection of porphyrins was noted by orange-pink
ﬂuorescence from colonies. P. acnes type I strains that produce high levels of porphyrins appeared with a more intense orange-pink color
than that with type II and III strains, as well as other Propionibacterium species, which produce low levels of porphyrins. Acne-associated
clade IC strain PV66 produced the most pigment compared to other type I strains, consistent with the higher porphyrin levels determined
by the extraction method (Fig. 1).
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microbial communities containing higher relative abundances of acne-associated
strains, such as clades IA-2, IB-1, and IC, may be at an increased risk of acne develop-
ment compared to individuals harboring lower abundances of these strains.
Compared to strains of types I and II, our understanding of the role of type III strains
in human health and disease is much more limited. It has been suggested that P. acnes
type III strains may play a role in the skin depigmentation disorder progressive macular
hypomelanosis (PMH) (24–27) based on the higher prevalence and abundance of type
III strains found in PMH lesions than other types, coupled with the visual observation
of increased porphyrin levels detected by the Wood’s lamp method (20). Furthermore,
when patients with PMH are treated with lymecycline and benzoyl peroxide, there is a
reduction in the size of their lesions that appears to parallel a reduction in type III
strains (26). In this study, using two P. acnes type III strains, one isolated from the
lesional skin (back) of a PMH patient (BR-16) and the other from the oral cavity
(HL201PA1), we found that both strains produced very low levels of porphyrins (Fig. 1).
Low porphyrin production by these strains was further corroborated by the lack of
signiﬁcant pigment observed when these strains were cultured on solid medium and
illuminated with a Wood’s lamp (Fig. 4). As skin often harbors multiple strains, with type
I strains being the most common, this would likely indicate that the ﬂuorescence
observed within a PMH lesion is primarily driven by type I strains. Culture-based studies
of punch biopsy specimens from lesional skin have, however, showed minimal evi-
dence for mixed strain types (24, 27), but this could reﬂect the limitation and bias of in
vitro culture. A recent metagenomic study, while corroborating the association of type
III strains with PMH, demonstrated the presence of various amounts of type I and II
strains in lesional samples in addition to type III strains. The analysis, however, was
based on surface skin swab samples rather than biopsy specimens as in the previous
study, and some potential issues around clear differentiation of lesional from nonle-
sional sites using this approach may have occurred (26). The differences among the
studies demonstrate that further work is required to improve our understanding of the
role of type III strains in PMH.
In addition to P. acnes, in this study, we investigated the porphyrin production of
other cutaneous propionibacteria, including P. granulosum, P. avidum, and P. humerusii.
We found that these species produce markedly low levels of porphyrins compared to
P. acnes (Fig. 3). We also revealed that unlike acne-associated P. acnes strains, these
cutaneous propionibacteria do not respond to vitamin B12 supplementation with
respect to porphyrin production (Fig. S2). Recently, using both 16S rRNA and metag-
enomic shotgun sequencing analyses of samples collected from acne patients and
healthy individuals, we revealed higher relative abundances of P. acnes type II strains,
as well as P. granulosum in the skin microbiome of individuals with healthy skin (7, 13).
Since individuals are often colonized by a community of mixed species and strain
populations (7, 13), the ratios of different propionibacteria and P. acnes strains may
ultimately determine the overall porphyrin production capability of an individual’s skin
microbiome. A higher relative abundance of low-porphyrin-producing propionibacte-
ria, such as P. acnes type II and P. granulosum, observed on healthy skin supports this
theory, with an overall low production of proinﬂammatory porphyrins, thus maintain-
ing a clinically healthy skin state.
The results from this study on the differential porphyrin-producing abilities of skin
propionibacteria support and expand our previous ﬁndings. Using metagenomic anal-
yses, we previously revealed that the balance of species, strains, and the overall
functional content of the skin microbiome is important to skin health and disease. In
this study, we quantitatively measured bacterial porphyrin production and highlighted
the differences in the proinﬂammatory output from distinct Propionibacterium popu-
lations that are representative of the key players in the skin microbiome. The overall
abundances of these distinct species and strains may ultimately deﬁne the combined
metabolic output of the skin community, which is an important factor in the virulence
potential of the resident skin microbiome in health and disease.
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MATERIALS AND METHODS
Bacterial strains. The Propionibacterium species and strains used in this study are listed in Table 1.
Strains were isolated as previously described by Fitz-Gibbon et al. (7). HL005PA2 and HL027PA2 were
selected to represent clade IA-1 strains, HL043PA1 and HL053PA1 were selected to represent clade IA-2
strains, HL053PA2 and HL082PA1 were selected to represent clade IB-1 strains, HL037PA1 and HL063PA2
were selected to represent clade IB-2 strains, KPA171202 and HL030PA1 were selected to represent clade
IB-3 strains, PV66 was selected to represent clade IC strains, HL001PA1, HL042PA3, and HL110PA3 were
selected to represent type II strains, and HL201PA1 and BR-16 were selected to represent type III strains.
Other propionibacteria strains include P. granulosum HL078PG1 and HL082PG1, P. avidum HL063PV1,
HL083PV1, and HL307PV1, and P. humerusii HL044PA1.
Bacterial culture conditions. Bacterial strains were cultured as described by Johnson et al. (8).
Brieﬂy, 5 ml of reinforced clostridial medium (RCM) was inoculated with 5 105 P. acnes cells per ml of
culture. Cultures were incubated anaerobically at 37°C in a light-protected box and grown to stationary
phase (approximately 10 to 14 days). The growth of the cultures was monitored throughout the
incubation period. For vitamin B12 supplementation, cultures were supplemented on day 0 with
10 g/ml vitamin B12 (Sigma-Aldrich) and incubated as described above. Unless otherwise stated, three
to eight independent experiments with at least four replicates per experiment were performed for each
strain. Bacterial cultures with no vitamin B12 supplementation and medium controls were performed
alongside the tests.
Extraction and quantiﬁcation of porphyrins. Porphyrins were extracted according to the method
described by Kang et al. (9). Brieﬂy, 500 l of stationary-phase bacterial cell culture was extracted in ethyl
acetate and acetic acid (4:1 [vol/vol]) and solubilized in 1.5 M hydrochloric acid. The absorbance at
405 nm was measured from 200 l of the soluble phase using a Genios M1000 spectrophotometer (Tecan
U.S., Inc., Morrisville, NC). A standard curve was generated using coproporphyrin III standards (Frontier
SCI) of known concentrations and used to convert absorbance to concentration. Bacterial culture density
was measured as the optical density at 595 nm (OD595) for normalization of porphyrin levels between
cultures.
Statistical analysis. The average level of porphyrins produced by each bacterial strain under each
culture condition was calculated based on the data from at least three independent experiments, with
at least four replicates for each trial, unless otherwise stated. Statistical signiﬁcance between porphyrin
levels produced by different strains or under different culture conditions (with vitamin B12 supplemen-
tation versus without supplementation) was analyzed using the Student’s t test. All statistical analyses
were performed using the R software (version 3.1.3).
deoR repressor gene expression analysis. The sequences of the deoR transcription repressor gene
(PPA0299) found upstream of the porphyrin biosynthesis operon in a number of Propionibacterium
strains (deoR-harboring strains) were aligned using the multiple-sequence alignment software MEGA7.0.
To detect the expression of the deoR gene in P. acnes strains KPA171202, PV66, and HL201PA1, total RNA
was extracted from log-phase cultures and puriﬁed using the RNeasy kit (Qiagen), according to the
manufacturer’s instructions. DNA was removed using the Turbo DNA-free kit (Life Technologies). RNA
quality and quantity were assessed by gel electrophoresis and NanoDrop spectrophotometer measure-
ments. Single-stranded cDNA was synthesized using SuperScript III ﬁrst-strand synthesis supermix (Life
Technologies). PCR was performed using the C1000 thermal cycler (Bio-Rad), with the following primers:
deoR-forward, 5=-CTGGCACGAGAAGGAACAA-3=; deoR-reverse, 5=-GAATCGAGCAGAACTAGGTCAC-3=;
recA-forward, 5=-GTCGCGTTGGGTGTCGGAGG-3=; and recA-reverse, 5=-GATGCCGCCTTCAGCCTGGG-3=. The
recA-forward and recA-reverse primers were used to analyze the expression of the housekeeping gene
recA as a positive control. The PCR cycles are as follows: initial denaturation at 95°C for 5 min, followed
by 35 cycles of 95°C for 10 s, 62°C for 30 s, and 72°C for 30 s, and then a ﬁnal extension cycle at 72°C
for 5 min. Ampliﬁed deoR and recA products were visualized on a 1.5% Tris-acetate-EDTA [TAE]–agarose
gel. The deoR-negative P. acnes strain HL037PA1 (clade IB-2) was used as a negative control for deoR
expression.
Visualization of porphyrins using the Wood’s lamp. Eleven Propionibacterium strains were cul-
tured on solid A-medium plates, including P. acnes type I (HL037PA1, KPA171202, and PV66), type II
(HL00PA1, HL042PA3, and HL110PA3), and type III (HL201PA1 and BR-16) strains, as well as P. granulosum
(HL082PG1), P. avidum (HL307PV1), and P. humerusii (HL044PA1) strains. Plates were incubated for 5 to
7 days in a light-protected box. Wood’s lamp examination was conducted under dark-room conditions,
with the lamp held approximately 20 cm from the medium plate.
SUPPLEMENTAL MATERIAL
Supplemental material is available online only.
FIG S1, PDF ﬁle, 0.1 MB.
FIG S2, PDF ﬁle, 0.1 MB.
FIG S3, PDF ﬁle, 0.1 MB.
FIG S4, PDF ﬁle, 0.1 MB.
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